在瘤生物学和免疫学中的迪斯科伊丁域受体:进展和挑战
Heng Zhang1, Wenlong Chen1, Haitao Zhu1
1Institute of Medical Imaging and Artificial Intelligence, Jiangsu University, Zhenjiang 212013, China.
Biomolecules
|June 26, 2025
概括
迪斯科伊丁域受体 (DDR) 调解细胞-ECM通信,影响瘤进展,免疫反应和治疗耐药性. 针对DDRs显示出作为癌症生物标志物和治疗策略的希望.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 瘤发生涉及复杂的癌细胞-细胞外基质 (ECM) 相互作用.
- 迪斯科伊丁域受体 (DDRs),原激活受体氨酸激酶,是细胞-ECM通信的关键媒介.
- DDRs调节关键癌症过程,如扩散,转移和治疗耐药性.
研究的目的:
- 审查DDR的发现,结构和功能.
- 检查瘤微环境中DDRs和原之间的相互调节.
- 探索DDRs在癌症进展,免疫调节和治疗策略中的作用.
主要方法:
- 对DDR和癌症研究的文献综述.
- 分析DDR的正规和非正规功能.
- 对DDR向疗法的当前研究进行综合.
主要成果:
- DDR在细胞增殖,细胞亡,分化,新陈代谢,转移和治疗耐药性方面发挥着重要作用.
- 瘤微环境中的DDRs和原之间的相互作用推动了癌症的进展.
- DDRs影响瘤免疫微环境和癌症细胞生物学.
结论:
- DDRs是癌细胞行为和瘤微环境的关键调节者.
- 向DDR具有作为新型癌症生物标志物和治疗策略的潜力.
- 对DDR的进一步研究可能会导致改善癌症治疗方法.
相关概念视频
01:15Receptor Downregulation in MVBs
2.2K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.2K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
01:27Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
01:26Signal Transduction: Overview
9.4K
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
9.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K